Top Section/Ad
Top Section/Ad
Most recent
Cell and gene therapy company plans US expansion
More articles/Ad
More articles/Ad
More articles
-
MPS has been on a strong run since its last recap, aided by rising interest rates in the eurozone -
Trustpilot’s stock has gained over 107% from a year ago, although it remains well below its IPO price
-
Block trade of €560m hedges JP Morgan position, cuts Stone Island family’s stake
-
A rerating of Lottomatica’s valuation has enabled Apollo to start exiting its position
-
US drug maker's stake in Haleon set to fall to 24%
-
Vår Energi has performed well since its flotation on the eve of the outbreak of war in Ukraine
